| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.24 | 0.0008 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0009 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 0.0009 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.23 | 0.001 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.003 |